Mitchell Kapoor

Stock Analyst at H.C. Wainwright

(4.16)
# 1,582
Out of 5,136 analysts
887
Total ratings
37.9%
Success rate
6.6%
Average return

Stocks Rated by Mitchell Kapoor

BioMarin Pharmaceutical
Nov 16, 2026
Reiterated: Hold
Price Target: $60
Current: $57.99
Upside: +3.47%
CRISPR Therapeutics AG
Nov 16, 2026
Reiterated: Buy
Price Target: $80
Current: $40.37
Upside: +98.17%
Damora Therapeutics
Nov 16, 2026
Reiterated: Buy
Price Target: $45
Current: $22.50
Upside: +100.04%
Ionis Pharmaceuticals
Nov 16, 2026
Reiterated: Buy
Price Target: $70
Current: $28.01
Upside: +149.91%
Century Therapeutics
Nov 16, 2026
Reiterated: Buy
Price Target: $5
Current: $1.64
Upside: +204.88%
Legend Biotech
Nov 16, 2026
Reiterated: Buy
Price Target: $65
Current: $15.99
Upside: +306.50%
Summit Therapeutics
Nov 16, 2026
Reiterated: Hold
Price Target: n/a
Current: $11.82
Upside: -
Alumis
Nov 13, 2026
Rated: Buy
Price Target: $15 → $9
Current: $5.14
Upside: +75.10%
Ascendis Pharma
Nov 13, 2026
Reiterated: Buy
Price Target: $344 → $335
Current: $271.73
Upside: +23.28%
Crescent Biopharma
Nov 13, 2026
Reiterated: Buy
Price Target: $36 → $40
Current: $13.50
Upside: +196.30%
Reiterated: Hold
Price Target: n/a
Current: $7.10
Upside: -
Reiterated: Buy
Price Target: $30
Current: $10.49
Upside: +185.99%
Reiterated: Buy
Price Target: $25
Current: $4.76
Upside: +425.21%
Reiterated: Buy
Price Target: $45 → $39
Current: $14.65
Upside: +166.21%
Reiterated: Buy
Price Target: $20
Current: $8.74
Upside: +128.83%
Reiterated: Buy
Price Target: $25
Current: $9.86
Upside: +153.55%
Reiterated: Buy
Price Target: $20
Current: $6.43
Upside: +211.04%
Reiterated: Buy
Price Target: $60
Current: $15.37
Upside: +290.37%
Initiated Coverage: Buy
Price Target: $90
Current: $53.12
Upside: +69.43%
Reiterated: Buy
Price Target: $7 → $5
Current: $1.03
Upside: +385.44%
Reiterated: Buy
Price Target: $29 → $27
Current: $19.74
Upside: +36.78%
Reiterated: Buy
Price Target: $5
Current: $1.87
Upside: +167.38%
Reiterated: Buy
Price Target: $65 → $60
Current: $23.30
Upside: +157.51%
Reiterated: Buy
Price Target: $120
Current: $99.24
Upside: +20.92%
Reiterated: Hold
Price Target: n/a
Current: $7.37
Upside: -
Reiterated: Buy
Price Target: $25
Current: $9.16
Upside: +172.93%
Reiterated: Buy
Price Target: $130
Current: $96.50
Upside: +34.72%
Reiterated: Buy
Price Target: $15
Current: $12.71
Upside: +18.02%
Reiterated: Buy
Price Target: $25
Current: $6.08
Upside: +311.18%
Reiterated: Sell
Price Target: $5
Current: $15.13
Upside: -66.95%
Reiterated: Buy
Price Target: $152
Current: $120.27
Upside: +26.38%
Reiterated: Buy
Price Target: kr 600.00
Current: kr 480.20
Upside: +24.95%
Reiterated: Buy
Price Target: $17 → $11
Current: $1.99
Upside: +454.16%
Reiterated: Buy
Price Target: $13 → $10
Current: $3.23
Upside: +209.60%
Downgraded: Hold
Price Target: n/a
Current: $5.75
Upside: -
Reiterated: Buy
Price Target: $4
Current: $2.41
Upside: n/a
Reiterated: Buy
Price Target: $7
Current: $0.68
Upside: n/a
Reiterated: Hold
Price Target: $3 → $2
Current: $1.08
Upside: n/a
Initiated Coverage: Buy
Price Target: $25
Current: $4.39
Upside: n/a
Rated: Hold
Price Target: n/a
Current: $15.43
Upside: n/a
Rated: Hold
Price Target: n/a
Current: $0.0002
Upside: n/a
Reiterated: Buy
Price Target: $9
Current: $0.5403
Upside: n/a
Reiterated: Buy
Price Target: $15
Current: $2.60
Upside: n/a
Reiterated: Hold
Price Target: $15
Current: $2.75
Upside: n/a